AERI Overview
Upcoming Projects (AERI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AERI)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (AERI)
-
A Second Look: Exploring Rocklatan's potential in treating Glaucoma with a prescribing physician
Ticker: AERI
Execute By: Aug 23, 2019
Upcoming & Overdue Catalysts (AERI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AERI)
-
Aerie (AERI) Resubmits of New Drug Application for Glaucoma Treatment Rhopressa
Ticker: AERI
Occurred on: Mar 01, 2017 -
Aerie's (AERI) NDA filing for Rhopressa in Lowering Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension Q3 2016
Ticker: AERI
Occurred on: Sep 06, 2016 -
Aerie Pharmaceuticals Completes Enrollment of Rocket 4 Phase 3 Clinical Trial of Rhopressa (netarsudil ophthalmic solution) 0.02%
Ticker: AERI
Occurred on: Jun 16, 2016 -
Safety data for the 12-month period of the Rocket 2 trial is expected early 2016
Ticker: AERI
Occurred on: Feb 17, 2016
Strategic Initiatives (AERI)
-
Aerie Pharmaceuticals (AERI) to Acquire Avizorex Pharma for Its Dry Eye Program
Ticker: AERI
Announcement Date: Nov 18, 2019
